EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of an out-of-pocket insulin cap in Medicare part D

Yevgeniy Feyman iD, Thomas Buchmueller iD

Health Affairs Scholar · 29.05.2026 · 4 (6)

DOI: 10.1093/haschl/qxag153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs Scholar, online erschienen am 16.06.2026. Verfasst von Yevgeniy Feyman und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Washington, Seattle, WA 98195, United States. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Out-of-pocket (OOP) costs can often impede patients' access to prescription drugs. The Inflation Reduction Act of 2022 (IRA) limited OOP costs for insulin products covered by the Medicare Part B and Part D programs to no more than $35 for a one-month supply.

Methods

This analysis uses prescription drug data from Medicare Part D and commercially insured patients along with a difference-in-differences specification to estimate changes in OOP costs among Medicare Part D enrollees after policy implementation.

Results

We estimate that the Part D enrollees most likely to be affected by the policy saw a $34.71 reduction in average OOP costs per prescription across all insulins compared to what might have occurred absent the policy in 2023.

Conclusion

These findings suggest that targeted limits on OOP costs for high-value drugs can reduce the cost burden for patients.

Schlagwörter

Stichwörter der Autor:innen

Inflation Reduction ActMedicareinsulinout-of-pocket spendingpart Dprescription drugs

Autor:innen und Institutionen

  • School of Pharmacy, University of Washington, Seattle, WA 98195, United States.
  • Ross School of Business, University of Michigan, Ann Arbor, MI 48109, United States.

ORCID-Profile: Yevgeniy Feyman, Thomas Buchmueller

Zitieren

APA

Feyman, Y., & Buchmueller, T. (2026). Effect of an out-of-pocket insulin cap in Medicare part D. Health Affairs Scholar, 4(6). https://doi.org/10.1093/haschl/qxag153

Vancouver

Feyman Y, Buchmueller T. Effect of an out-of-pocket insulin cap in Medicare part D. Health Affairs Scholar. 2026;4(6). doi:10.1093/haschl/qxag153

BibTeX
@article{Feyman2026,
  author = {Feyman, Yevgeniy and Buchmueller, Thomas},
  title = {Effect of an out-of-pocket insulin cap in Medicare part D},
  journal = {Health Affairs Scholar},
  year = {2026},
  volume = {4},
  number = {6},
  doi = {10.1093/haschl/qxag153}
}
Kostenlos starten →